Abivax stock soars after ulcerative colitis drug helps harder-to-treat patients

Investing.com Gold reports: Abivax stock soars after ulcerative colitis drug helps harder-to-treat patients. Full body text was unavailable at ingest time, so this brief is based on headline context.